Solicitation of Nominations for Membership To Serve on the Advisory Committee on Heritable Disorders in Newborns and Children, 17308-17309 [2022-06367]
Download as PDF
<![CDATA[
jspears on DSK121TN23PROD with NOTICES1
17308
Federal Register / Vol. 87, No. 59 / Monday, March 28, 2022 / Notices
after the date that is 1 year from the
Secretary’s adoption of the condition.
ACHDNC also provides advice and
recommendations to the Secretary
concerning grants, projects and
technical information to develop
policies and priorities for grants,
including those that will enhance the
ability of the state and local health
agencies to provide for newborn and
child screening, counseling, and health
care services for newborns and children
having or at risk for heritable disorders.
ACHDNC meets four times each
calendar year, or at the discretion of the
DFO in consultation with the Chair.
Nominations: The Committee may
invite organizations to designate
individuals to serve as non-voting
liaisons. Organizations should
demonstrate wide-ranging newborn
screening and heritable disorders
interests. In addition, the organization’s
work should inform the activities of the
Committee. Eligible organizations must
represent national public health
constituencies, medical professional
societies, or organizations with large,
broad constituencies and broad interest
or involvement in newborn screening.
Organizations that represent narrow
interests (e.g., interest in a single disease
treatment) or smaller constituencies are
not eligible. Organizational
representatives attend Committee
meetings to provide relevant expertise
and perspectives to Committee members
during their deliberations and
discussions, but they do not vote and
are not official members of the
Committee.
Applications must contain a cover
letter and statement. The cover letter
should include the organization name
and mission statement; contact
information for the designated
representative, including point of
contact name, address, email, telephone
number; and website of the
organization. The statement should
include the perspective and expertise
provided by the organization and its
relevance to the Committee; description
of how the Committee’s work affects
and impacts the organization and its
constituency; a list of organizational
projects, programs, and products that
are of relevance to the Committee’s
work; an affirmation of the
organization’s commitment to identify a
representative with expertise who can
attend Committee meetings in person
(when applicable) and provide input to
the Committee at the discretion of the
Chair; an affirmation of the
organization’s commitment to
financially support (e.g., cover travel
expenses) a representative to attend any
in-person Committee meetings held in
VerDate Sep<11>2014
17:30 Mar 25, 2022
Jkt 256001
Rockville, Maryland; an affirmation of
the organization’s commitment to
ensure active contribution to and
dissemination of Committee activities
and recommendations to its
constituencies; affirmation the
designated representative is able to
serve as the liaison; and an affirmation
that the organization has no conflict of
interest that would preclude informing
the Committee in a fair and balanced
manner. If there are potential conflicts
of interest, please detail the information
concerning any potential conflicts of
interest relative to both the organization
and the proposed organizational
representative (e.g., current or
anticipated employment, consultancies,
research grants, or contracts), as well as
how the organization proposes to
address the potential conflict.
Organizations are eligible to send a
representative as long as the
organization’s subject area of expertise
and mission is relevant to the
Committee’s purpose, objective, scope
of activities and duties, and as long as
the organization actively participates in
Committee activities. Every 3 years, the
Chair and DFO will re-assess the
organization’s mission, relevancy, and
benefit as it relates to the Committee’s
purpose, objective, scope of activities
and duties. Every 3 years, current
organizations will be asked to reaffirm
their commitment to support an
organizational representative.
The selection of eligible organizations
is based on a review of the
organization’s subject area of expertise,
mission, relevancy, and benefit as it
relates to the Committee’s purpose.
Authority: Section 1111(g) of the
Public Health Service Act, 42 U.S.C.
300b–10(g), Section 222 of the Public
Health Service Act, 42 U.S.C. 217a, and
the Federal Advisory Committee Act, 5
U.S.C. App.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2022–06368 Filed 3–25–22; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Solicitation of Nominations for
Membership To Serve on the Advisory
Committee on Heritable Disorders in
Newborns and Children
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services (HHS).
AGENCY:
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
ACTION:
Request for nominations.
HRSA is seeking nominations
of qualified candidates for consideration
for appointment as members of the
Advisory Committee on Heritable
Disorders in Newborns and Children
(ACHDNC or Committee). ACHDNC
provides advice, recommendations, and
technical information about aspects of
heritable disorders and newborn and
childhood screening to the Secretary of
HHS (Secretary). HRSA is seeking
nominations of qualified candidates for
appointment to two positions on the
Committee beginning in 2023, each
serving a term of up-to 4 years.
DATES: Written nominations for
membership on the Committee must be
received on or before April 11, 2022.
ADDRESSES: Nomination packages must
be submitted electronically as email
attachments to Soohyun Kim, MPH,
CPH, Acting Designated Federal Officer
(DFO) at ACHDNC@hrsa.gov.
FOR FURTHER INFORMATION CONTACT:
Acting DFO Soohyun Kim, MPH, CPH;
Maternal and Child Health Bureau,
HRSA, 5600 Fishers Lane, Room 18–N–
38A, Rockville, MD 20857; 301–594–
4202; or ACHDNC@hrsa.gov. A copy of
the Committee charter and list of the
current membership is available on the
Committee’s website at https://
www.hrsa.gov/advisory-committees/
heritable-disorders/about/.
SUPPLEMENTARY INFORMATION: ACHDNC
was established in 2003 to provide
advice and recommendations to the
Secretary on the development of
newborn screening activities,
technologies, policies, guidelines, and
programs for effectively reducing
morbidity and mortality in newborns
and children having, or at risk for,
heritable disorders. ACHDNC reviews
and reports regularly on newborn and
childhood screening practices for
heritable disorders, recommends
improvements in the national newborn
and childhood heritable screening
programs, recommends conditions for
inclusion in the Recommended Uniform
Screening Panel (RUSP), and fulfills
requirements stated in the authorizing
legislation. ACHDNC’s
recommendations regarding inclusion of
additional conditions/inherited
disorders for screening that, when
adopted by the Secretary, are included
in the RUSP, and constitute part of the
evidence-informed comprehensive
preventive health services guidelines
supported by HRSA pursuant to section
2713 of the Public Health Service Act
(42 U.S.C. 300gg–13). Under this
provision, non-grandfathered group
health plans and group and individual
SUMMARY:
E:\FR\FM\28MRN1.SGM
28MRN1
jspears on DSK121TN23PROD with NOTICES1
Federal Register / Vol. 87, No. 59 / Monday, March 28, 2022 / Notices
health insurance issuers are required to
provide insurance coverage without
cost-sharing (a co-payment, coinsurance, or deductible) for preventive
services for plan years (i.e., in the
individual market, policy years)
beginning on or after the date that is 1
year from the Secretary’s adoption of the
condition.
ACHDNC also provides advice and
recommendations to the Secretary
concerning grants, projects and
technical information to develop
policies and priorities for grants,
including those that will enhance the
ability of the state and local health
agencies to provide for newborn and
child screening, counseling, and health
care services for newborns and children
having or at risk for heritable disorders.
ACHDNC meets four times each
calendar year, or at the discretion of the
Acting DFO in consultation with the
Chair.
Nominations: HRSA is requesting
nominations for voting members to
serve as Special Government Employees
(SGEs) on the ACHDNC to fill two
positions starting in 2023. The Secretary
appoints ACHDNC members with the
expertise needed to fulfill the duties of
the Committee. The membership
requirements are set forth in Title XI
§ 1111(g), 42 U.S.C. 300b–10(g).
Nominees sought are medical, technical,
or scientific professionals with special
expertise in the field of heritable
disorders or in providing screening,
counseling, testing, or specialty services
for newborns and children with, or at
risk for having, heritable disorders;
individuals who have expertise in ethics
(e.g., bioethics) and infectious diseases
and who have worked and published
material in the area of newborn
screening; members of the public having
demonstrated expertise about or
concern with heritable disorders; and/or
representatives from such federal
agencies, public health constituencies,
and medical professional societies with
such expertise. Interested applicants
may self-nominate or be nominated by
another individual or organization.
Individuals selected for appointment
to the Committee will be invited to
serve for a term of up-to 4 years.
Members appointed as SGEs receive a
stipend and reimbursement for per diem
and travel expenses incurred for
attending ACHDNC meetings and/or
conducting other business on behalf of
ACHDNC, as authorized by 5 U.S.C.
5703 for persons employed
intermittently in government service.
The following information must be
included in the package of materials
submitted for each individual
nominated for consideration: (1) A
VerDate Sep<11>2014
17:30 Mar 25, 2022
Jkt 256001
statement that includes the name and
affiliation of the nominee and a clear
statement regarding the basis for the
nomination, including the area(s) of
demonstrated expertise or concern that
may support eligibility of a nominee for
service on the Committee, as described
above; (2) confirmation the nominee is
willing to serve as a member of the
Committee; (3) the nominee’s contact
information (please include home
address, work address, daytime
telephone number, and an email
address); and (4) a current copy of the
nominee’s curriculum vitae.
Nomination packages may be submitted
directly by the individual being
nominated or by the person/
organization recommending the
candidate.
HHS endeavors to ensure that the
membership of ACHDNC is fairly
balanced in terms of points of view
represented and that individuals from a
broad representation of geographic
areas, gender, and ethnic and minority
groups, as well as individuals with
disabilities, are considered for
membership. Appointments shall be
made without discrimination on the
basis of age, ethnicity, gender, sexual
orientation, or cultural, religious, or
socioeconomic status.
Individuals selected for further
consideration for appointment will be
required to provide detailed information
regarding their financial holdings,
consultancies, and research grants or
contracts. Disclosure of this information
is required in order for HRSA ethics
officials to determine whether there is a
potential conflict of interest between the
SGE’s public duties as a member of
ACHDNC and their private interests,
including an appearance of a loss of
impartiality as defined by federal laws
and regulations, and to identify any
required remedial action needed to
address the potential conflict.
Authority: Section 1111(g) of the
Public Health Service Act, 42 U.S.C
300b–10(g), Section 222 of the Public
Health Service Act, 42 U.S.C. 217a, and
the Federal Advisory Committee Act, 5
U.S.C. App.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2022–06367 Filed 3–25–22; 8:45 am]
BILLING CODE 4165–15–P
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
17309
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Submission to OMB for
Review and Approval; Telehealth
Resource Center Performance
Measurement Tool, OMB No. 0915–
0361—Extension
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
ACTION: Notice.
AGENCY:
In compliance with of the
Paperwork Reduction Act of 1995,
HRSA has submitted an Information
Collection Request (ICR) to the Office of
Management and Budget (OMB) for
review and approval. Comments
submitted during the first public review
of this ICR will be provided to OMB.
OMB will accept further comments from
the public during the review and
approval period. OMB may act on
HRSA’s ICR only after the 30-day
comment period for this Notice has
closed.
SUMMARY:
Comments on this ICR should be
received no later than April 27, 2022.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under Review—Open for
Public Comments’’ or by using the
search function.
FOR FURTHER INFORMATION CONTACT: To
request a copy of the clearance requests
submitted to OMB for review, email
Samantha Miller, the acting HRSA
Information Collection Clearance Officer
at paperwork@hrsa.gov or call (301)
443–9094.
SUPPLEMENTARY INFORMATION:
Information Collection Request Title:
Telehealth Resource Center (TRC)
Performance Measurement Tool, OMB
No. 0915–0361—Extension.
Abstract: HRSA requests an extension
of their TRC Performance Measurement
Tool. The TRCs deliver telehealth
technical assistance. There are two
types of HRSA TRC programs:
• Two National Telehealth Resource
Center Programs focus on policy and
technology.
• Twelve Regional Telehealth
Resource Center Programs host activities
and provide resources to rural and
underserved areas.
DATES:
E:\FR\FM\28MRN1.SGM
28MRN1
]]>Agencies
[Federal Register Volume 87, Number 59 (Monday, March 28, 2022)]
[Notices]
[Pages 17308-17309]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-06367]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Solicitation of Nominations for Membership To Serve on the
Advisory Committee on Heritable Disorders in Newborns and Children
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services (HHS).
ACTION: Request for nominations.
-----------------------------------------------------------------------
SUMMARY: HRSA is seeking nominations of qualified candidates for
consideration for appointment as members of the Advisory Committee on
Heritable Disorders in Newborns and Children (ACHDNC or Committee).
ACHDNC provides advice, recommendations, and technical information
about aspects of heritable disorders and newborn and childhood
screening to the Secretary of HHS (Secretary). HRSA is seeking
nominations of qualified candidates for appointment to two positions on
the Committee beginning in 2023, each serving a term of up-to 4 years.
DATES: Written nominations for membership on the Committee must be
received on or before April 11, 2022.
ADDRESSES: Nomination packages must be submitted electronically as
email attachments to Soohyun Kim, MPH, CPH, Acting Designated Federal
Officer (DFO) at [email protected].
FOR FURTHER INFORMATION CONTACT: Acting DFO Soohyun Kim, MPH, CPH;
Maternal and Child Health Bureau, HRSA, 5600 Fishers Lane, Room 18-N-
38A, Rockville, MD 20857; 301-594-4202; or [email protected]. A copy of
the Committee charter and list of the current membership is available
on the Committee's website at https://www.hrsa.gov/advisory-committees/heritable-disorders/about/.
SUPPLEMENTARY INFORMATION: ACHDNC was established in 2003 to provide
advice and recommendations to the Secretary on the development of
newborn screening activities, technologies, policies, guidelines, and
programs for effectively reducing morbidity and mortality in newborns
and children having, or at risk for, heritable disorders. ACHDNC
reviews and reports regularly on newborn and childhood screening
practices for heritable disorders, recommends improvements in the
national newborn and childhood heritable screening programs, recommends
conditions for inclusion in the Recommended Uniform Screening Panel
(RUSP), and fulfills requirements stated in the authorizing
legislation. ACHDNC's recommendations regarding inclusion of additional
conditions/inherited disorders for screening that, when adopted by the
Secretary, are included in the RUSP, and constitute part of the
evidence-informed comprehensive preventive health services guidelines
supported by HRSA pursuant to section 2713 of the Public Health Service
Act (42 U.S.C. 300gg-13). Under this provision, non-grandfathered group
health plans and group and individual
[[Page 17309]]
health insurance issuers are required to provide insurance coverage
without cost-sharing (a co-payment, co-insurance, or deductible) for
preventive services for plan years (i.e., in the individual market,
policy years) beginning on or after the date that is 1 year from the
Secretary's adoption of the condition.
ACHDNC also provides advice and recommendations to the Secretary
concerning grants, projects and technical information to develop
policies and priorities for grants, including those that will enhance
the ability of the state and local health agencies to provide for
newborn and child screening, counseling, and health care services for
newborns and children having or at risk for heritable disorders.
ACHDNC meets four times each calendar year, or at the discretion of
the Acting DFO in consultation with the Chair.
Nominations: HRSA is requesting nominations for voting members to
serve as Special Government Employees (SGEs) on the ACHDNC to fill two
positions starting in 2023. The Secretary appoints ACHDNC members with
the expertise needed to fulfill the duties of the Committee. The
membership requirements are set forth in Title XI Sec. 1111(g), 42
U.S.C. 300b-10(g). Nominees sought are medical, technical, or
scientific professionals with special expertise in the field of
heritable disorders or in providing screening, counseling, testing, or
specialty services for newborns and children with, or at risk for
having, heritable disorders; individuals who have expertise in ethics
(e.g., bioethics) and infectious diseases and who have worked and
published material in the area of newborn screening; members of the
public having demonstrated expertise about or concern with heritable
disorders; and/or representatives from such federal agencies, public
health constituencies, and medical professional societies with such
expertise. Interested applicants may self-nominate or be nominated by
another individual or organization.
Individuals selected for appointment to the Committee will be
invited to serve for a term of up-to 4 years. Members appointed as SGEs
receive a stipend and reimbursement for per diem and travel expenses
incurred for attending ACHDNC meetings and/or conducting other business
on behalf of ACHDNC, as authorized by 5 U.S.C. 5703 for persons
employed intermittently in government service.
The following information must be included in the package of
materials submitted for each individual nominated for consideration:
(1) A statement that includes the name and affiliation of the nominee
and a clear statement regarding the basis for the nomination, including
the area(s) of demonstrated expertise or concern that may support
eligibility of a nominee for service on the Committee, as described
above; (2) confirmation the nominee is willing to serve as a member of
the Committee; (3) the nominee's contact information (please include
home address, work address, daytime telephone number, and an email
address); and (4) a current copy of the nominee's curriculum vitae.
Nomination packages may be submitted directly by the individual being
nominated or by the person/organization recommending the candidate.
HHS endeavors to ensure that the membership of ACHDNC is fairly
balanced in terms of points of view represented and that individuals
from a broad representation of geographic areas, gender, and ethnic and
minority groups, as well as individuals with disabilities, are
considered for membership. Appointments shall be made without
discrimination on the basis of age, ethnicity, gender, sexual
orientation, or cultural, religious, or socioeconomic status.
Individuals selected for further consideration for appointment will
be required to provide detailed information regarding their financial
holdings, consultancies, and research grants or contracts. Disclosure
of this information is required in order for HRSA ethics officials to
determine whether there is a potential conflict of interest between the
SGE's public duties as a member of ACHDNC and their private interests,
including an appearance of a loss of impartiality as defined by federal
laws and regulations, and to identify any required remedial action
needed to address the potential conflict.
Authority: Section 1111(g) of the Public Health Service Act, 42
U.S.C 300b-10(g), Section 222 of the Public Health Service Act, 42
U.S.C. 217a, and the Federal Advisory Committee Act, 5 U.S.C. App.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2022-06367 Filed 3-25-22; 8:45 am]
BILLING CODE 4165-15-P
